SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Morgan Stanley Maintains Overweight on Amgen, Lowers Price Target to $273

Morgan Stanley maintains Amgen (NASDAQ:AMGN) with a Overweight and lowers the price target from $281 to $273.

· 10/13/2020 08:19
Morgan Stanley maintains Amgen (NASDAQ:AMGN) with a Overweight and lowers the price target from $281 to $273.